Y49: Psychotropic drugs, not elsewhere classified
Y49.4: Butyrophenone and thioxanthene neuroleptics
Butyrophenone and thioxanthene neuroleptics are a classification of medications that are often used in the treatment of certain psychiatric conditions, such as schizophrenia. They work by altering the balance of chemicals within the brain. However, as with many medications, there are potential adverse effects. In some cases, these can affect the nervous system, leading to a condition known as neuroleptic-induced movement disorder. This disorder can cause involuntary movements, such as tremors, stiffness, and slow movement. Symptoms often present gradually and can worsen over time if the medication intake is not managed or adjusted. The range and severity of symptoms can vary widely from individual to individual and may be influenced by factors such as the dose of medication and the duration of treatment.
Patient Disclaimer
The information provided on this page is for general educational purposes only. It is not intended for self-diagnosis and does not replace professional medical advice. Always consult your doctor or a qualified healthcare provider with any questions or concerns about your health.
If you see an ICD diagnosis code (e.g., on a medical report), be aware that doctors may also include additional indicators to express diagnostic certainty. Only a healthcare professional can interpret these codes accurately in the context of your individual case.
For a complete understanding of your condition and what the diagnosis means for you, please speak directly with your doctor.